Vibegron

🧮 Dose calculator

Overactive bladder · Regimen source: FDA Gemtesa · 2.1

• • With or without food; in adults may be crushed into applesauce. FDA Gemtesa · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Gemtesa · 8.1

  “Risk Summary There are no available data on GEMTESA use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Gemtesa · 8.2

  “Risk Summary There are no data on the presence of vibegron in human milk, the effects of the drug on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Gemtesa · 8.4

  “The safety and effectiveness of GEMTESA in pediatric patients have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Gemtesa · 8.5

  “No overall differences in safety or effectiveness of GEMTESA have been observed between patients 65 years of age and older and younger adult patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.